UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

European neuropsychopharmacology, 2010-09, Vol.20 (9), p.641-654

2010

Volltextzugriff (PDF)

Noradrenergic mechanisms in neurodegenerative diseases: a theory

Brain Research Reviews, 2004-04, Vol.45 (1), p.38-78

2004

Volltextzugriff (PDF)

Discovering risperidone: the LSD model of psychopathology

Nature reviews. Drug discovery, 2003-04, Vol.2 (4), p.315-320

Colpaert, Francis C

2003

Volltextzugriff (PDF)

Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study

Neuropharmacology, 2009-02, Vol.56 (2), p.350-361

2009

Volltextzugriff (PDF)

The Alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells

Neuropsychopharmacology (New York, N.Y.), 2006-06, Vol.31 (6), p.1146-1157

2006

Volltextzugriff (PDF)

5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy

European journal of pharmacology, 2002-10, Vol.453 (2-3), p.217-221

2002

Volltextzugriff (PDF)

High-Efficacy 5-HT1A Agonists for Antidepressant Treatment: A Renewed Opportunity

Journal of medicinal chemistry, 2007-10, Vol.50 (20), p.5024-5033

2007

Volltextzugriff (PDF)

High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning

The Journal of pharmacology and experimental therapeutics, 2006-02, Vol.316 (2), p.892-899

2006

Volltextzugriff (PDF)

PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

European journal of pharmacology, 2002-01, Vol.435 (2), p.143-151

2002

Volltextzugriff (PDF)

Curative-like analgesia in a neuropathic pain model : Parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT1A receptor agonist

European journal of pharmacology, 2007-07, Vol.568 (1-3), p.134-141

2007

Volltextzugriff (PDF)

Recall of learned information may rely on taking drug again

Nature (London), 2009-01, Vol.457 (7229), p.533-533

2009

Volltextzugriff (PDF)

Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress

Journal of neurochemistry, 2001-10, Vol.79 (1), p.200-210

2001

Volltextzugriff (PDF)

The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes

Experimental neurology, 2005, Vol.191 (1), p.174-183

2005

Volltextzugriff (PDF)

The Neurotransmitter Noradrenaline Rescues Septal Cholinergic Neurons in Culture from Degeneration Caused by Low-Level Oxidative Stress

Molecular pharmacology, 2005-06, Vol.67 (6), p.1882-1891

2005

Volltextzugriff (PDF)

Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain

The Journal of pharmacology and experimental therapeutics, 2003-08, Vol.306 (2), p.505

2003

Volltextzugriff (PDF)

Long-lasting descending and transitory short-term spinal controls on deep spinal dorsal horn nociceptive-specific neurons in response to persistent nociception

Brain research bulletin, 2008-01, Vol.75 (1), p.34-41

2008

Volltextzugriff (PDF)

Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance

Trends in pharmacological sciences (Regular ed.), 2003-12, Vol.24 (12), p.634-639

2003

Volltextzugriff (PDF)

Activation of the Mitogen-Activated Protein Kinase (ERK1/2) Signaling Pathway by Cyclic AMP Potentiates the Neuroprotective Effect of the Neurotransmitter Noradrenaline on Dopaminergic Neurons

Molecular pharmacology, 2002-11, Vol.62 (5), p.1043-1052

2002

Volltextzugriff (PDF)

In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia

European journal of pharmacology, 2001-06, Vol.421 (2), p.109-114

2001

Volltextzugriff (PDF)

The 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain

European journal of pharmacology, 2002-12, Vol.456 (1-3), p.51-57

2002

Volltextzugriff (PDF)

Activation of noradrenergic transmission by α2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb

Experimental neurology, 2005-08, Vol.194 (2), p.444-456

2005

Volltextzugriff (PDF)

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

European journal of pharmacology, 2001-05, Vol.420 (2-3), p.103-112

2001

Volltextzugriff (PDF)

High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury

European journal of pharmacology, 2004-08, Vol.497 (1), p.29-33

2004

Volltextzugriff (PDF)

Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model : A c-Fos study

European journal of pharmacology, 2005-05, Vol.514 (2-3), p.121-130

2005

Volltextzugriff (PDF)

The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury

European journal of pharmacology, 2003-10, Vol.478 (2-3), p.131-137

2003

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(215)

Publikationsform

Artikel
(237)
Buchkapitel
(3)

Sprache

Englisch
(240)

Erscheinungsjahr

n.n

Thema

Animals
(123)
Science & Technology
(123)
Life Sciences & Biomedicine
(122)
Rats
(92)
Pharmacology & Pharmacy
(86)
Male
(79)
Biological And Medical Sciences
(72)
Medical Sciences
(59)
Pharmacology. Drug Treatments
(49)
Neurosciences
(46)
Neurosciences & Neurology
(45)
Humans
(44)
Dose-Response Relationship, Drug
(39)
Rats, Sprague-Dawley
(31)
Neuropharmacology
(29)
5-Ht
(26)
Time Factors
(21)
Piperidines - Pharmacology
(20)
Serotonin Receptor Agonists - Pharmacology
(20)
Drug Discrimination
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

F15599, a preferential post-synaptic 5-HT1A receptor agonist: Activity in models of cognition in comparison with reference 5-HT1A receptor agonists

Noradrenergic mechanisms in neurodegenerative diseases: a theory

Discovering risperidone: the LSD model of psychopathology

Region-specific changes in 5-HT1A agonist-induced Extracellular signal-Regulated Kinases 1/2 phosphorylation in rat brain: a quantitative ELISA study

The Alpha2-adrenoceptor antagonist dexefaroxan enhances hippocampal neurogenesis by increasing the survival and differentiation of new granule cells

5-HT1A receptor activation and anti-cataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy

High-Efficacy 5-HT1A Agonists for Antidepressant Treatment: A Renewed Opportunity

High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning

PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

Curative-like analgesia in a neuropathic pain model : Parametric analysis of the dose and the duration of treatment with a high-efficacy 5-HT1A receptor agonist

Recall of learned information may rely on taking drug again

Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress

The novel analgesic and high-efficacy 5-HT1A receptor agonist F 13640 inhibits nociceptive responses, wind-up, and after-discharges in spinal neurons and withdrawal reflexes

The Neurotransmitter Noradrenaline Rescues Septal Cholinergic Neurons in Culture from Degeneration Caused by Low-Level Oxidative Stress

Continuous administration of the 5-hydroxytryptamine1A agonist (3-Chloro-4-fluoro-phenyl)-[4-fluoro-4-[[(5-methyl-pyridin-2-ylmethyl) -amino]-methyl]piperidin-1-yl]-methadone (F 13640) attenuates allodynia-like behavior in a rat model of trigeminal neuropathic pain

Long-lasting descending and transitory short-term spinal controls on deep spinal dorsal horn nociceptive-specific neurons in response to persistent nociception

Opioid hyperalgesia and tolerance versus 5-HT1A receptor-mediated inverse tolerance

Activation of the Mitogen-Activated Protein Kinase (ERK1/2) Signaling Pathway by Cyclic AMP Potentiates the Neuroprotective Effect of the Neurotransmitter Noradrenaline on Dopaminergic Neurons

In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia

The 5-HT1A receptor agonist F 13640 attenuates mechanical allodynia in a rat model of trigeminal neuropathic pain

Activation of noradrenergic transmission by α2-adrenoceptor antagonists counteracts deafferentation-induced neuronal death and cell proliferation in the adult mouse olfactory bulb

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

High-efficacy 5-HT1A receptor activation causes a curative-like action on allodynia in rats with spinal cord injury

Effects of the high-efficacy 5-HT1A receptor agonist, F 13640 in the formalin pain model : A c-Fos study

The very-high-efficacy 5-HT1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury

Suchergebnisse filtern